CLLS - CIK 0001627281
The table below shows Cellectis S.A.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $93.52M | $90.54M | $87.65M | $97.50M | $117.84M | $77.05M |
| SG&A | $19.79M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $19.09M |
| $16.81M |
| $17.49M |
| $22.88M |
| $22.51M |
| Operating income | - | - | - | - | - | - |
| Income tax | - | - | - | - | - | - |
| Net income | - | - | - | - | - | - |
| EPS (diluted) | - | - | - | - | - | - |